Focada exclusivamente no desenvolvimento, 
                                        produção e promoção de produtos farmacêuticos especializados

Hecho Relevante – Restructuración del Management*


BIOTOSCANA INVESTMENTS S.A. («Company» or «GBT») (B3: GBIO33), a leading biopharmaceutical company in Latin America, announces to its shareholders and the market in general a realignment of its management structure to better suit the company´ strategy. To gain speed and focus on new launches in key geographies Mr. Mariano García-Valiño (CEO of Grupo Biotoscana) will take direct responsibility for overseeing Brazil and Argentina, the two largest operations of the company.

At the same time, the company is creating the position of Executive Vice President (EVP), Andean Region, which will be filled by GBT-veteran, Ms. Julieta Serna. This new position will be responsible for leading operations in Bolivia, Colombia, Chile, Ecuador, Mexico, Paraguay, Peru and Uruguay, reporting directly to Mr. García-Valiño.

Ms. Serna, a member of the original team that conceptualized the company together with Mr. Garcia-Valino at Advent International, has been instrumental in GBT’s development in several fronts. Most recently, she was the company’s Chief Strategy Officer. The company is in the final stages of recruiting to replace Julieta’s old position. In the meantime, Nuno Toscano, from Advent’s Portfolio Support Group, will temporarily fill the role.

As a result, Mr. Jorge Ramos (COO) will leave the company. GBT thanks Mr. Ramos for his help and wish him success in his future endeavors.

Montevideo, October 24, 2017.

Claudio Coracini
Legal representative in Brazil

To access the material fact in PDF format, click here.

Actualizado el 02/01/2019 - 11:40